University of Michigan Rogel Cancer Center: Head and Neck Neoplasms trials

The registry lists 12 Head and Neck Neoplasms studies with University of Michigan Rogel Cancer Center as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 2 6No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Expansion Trial for Axitinib In Head And Neck CancerCompletedNCT02762513Phase 2Results posted
• A Study Using Cone Beam CT for Head and Neck CancerCompletedNCT01661062Not applicableResults posted
• Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck CancerCompletedNCT01469546Phase 2Results posted
• Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)TerminatedNCT00904345Phase 2Results posted
• Optimized Intensity Modulated Irradiation for Head and Neck CancerCompletedNCT00580983Not applicableResults posted
• A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck CancerCompletedNCT00148122Phase 2Results posted
• Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing SurgeryWithdrawnNCT06094621
• Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing ChemoradiotherapyTerminatedNCT02485470Phase 2
• A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management Clinic for Head and Neck Cancer Patients Undergoing Concurrent Chemotherapy and RadiationWithdrawnNCT02085525Not applicable
• A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck CancerWithdrawnNCT02013453Phase 2
• Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive TherapyCompletedNCT01794481Not applicable
• Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck CancerCompletedNCT01663246Not applicable